A detailed history of Smartleaf Asset Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 31 shares of PCRX stock, worth $515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 267 88.39%
Holding current value
$515
Previous $7.45 Million 93.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.7 - $28.46 $2,761 - $6,716
-236 Reduced 88.39%
31 $450,000
Q2 2024

Aug 13, 2024

BUY
$25.5 - $31.51 $6,808 - $8,413
267 New
267 $7.45 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $763M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.